Out of four markers of nervous system cell injury, blood levels of neurofilament light chain (NfL) were found to best…
Articles by Patricia Inacio, PhD
In a racially diverse group of people with neuromyelitis optica spectrum disorder (NMOSD), rituximab worked better to prevent relapses…
Plasma exchange, a blood-cleaning procedure, is safe and helps to ease symptoms in elderly people with neuromyelitis optica spectrum…
SPHERES, a real-world registry designed to better understand neuromyelitis optica spectrum disorder (NMOSD) — its underlying mechanisms, clinical…
People who are younger at the onset of neuromyelitis optica spectrum disorder (NMOSD) and those with multiple organ involvement…
A rare case of neuromyelitis optica spectrum disorder (NMOSD) in a patient positive for antibodies against both aquaporin-4 (AQP4) protein…
Ofatumumab, a medication approved for multiple sclerosis (MS), effectively prevented relapses and disability progression in a 67-year old woman…
Being positive for or showing high levels of antibodies against the aquaporin-4 (AQP4) protein at diagnosis doesn’t predict worse…
A low dose of rituximab — infused at 100 mg weekly for three consecutive weeks — was effective at…
Vaccination against SARS-CoV-2, the virus that causes COVID-19, may trigger neuromyelitis optica spectrum disorder (NMOSD), a case report suggests.